Aromatase inhibitors: all 608 studies that test it
Page 5 of 7. Open to participants first (88), then studies with results posted, then the rest; newest registration first within each.
- Overcoming Endocrine Resistance in Metastatic Breast CancerStatus unknownNCT02394496Phase 3
- Endocrinology Profile in Patients Undergoing Clomiphene, Letrozole, and Combination Clomiphene and Letrozole CyclesWithdrawnNCT02377479Not applicable
- Detect V / CHEVENDO (Chemo vs. Endo)Active, not recruitingNCT02344472Phase 3
- Trial of Perioperative Endocrine Therapy - Individualising CareActive, not recruitingNCT02338310Phase 3
- Comparison Between Letrozole and Laparoscopic Ovarian Drilling in Women With Clomiphene Resistant Polycystic Ovarian Syndrome (PCOS)Status unknownNCT02305693Phase 3
- Comparison Between Letrozole and Urinary Purified FSH in Women With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome.CompletedNCT02304107Phase 3
- Outcome of Three Controlled Ovarian Hyperstimulation Protocols in Poor Responding Infertility PatientsCompletedNCT02293668Not applicable
- Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With BevacizumabCompletedNCT02248571Phase 4
- Neoadjuvant Trastuzumab and Letrozole for Postmenopausal WomenStatus unknownNCT02214004Phase 2
- Comparison of Treatment Modalities in Poor Responders Undergoing IVFCompletedNCT02158689Not applicable
- Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive PatientsCompletedNCT02152943Phase 1
- Comparison of 2 Ovarian Stimulation Protocols for Women With Low Ovarian ReserveStatus unknownNCT02128360Not applicable
- Influence of Aromatase Inhibition on Hepatic- and Cardiac Function in Severe Obese MenCompletedNCT02097680Phase 4
- Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast CancerStatus unknownNCT02097459Phase 3
- Adjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast CancerStatus unknownNCT02089854Phase 4
- CR1447 in Endocrine Responsive-HER2neg and TN-ARpos Breast CancerTerminatedNCT02067741Phase 2
- Impact of Endogenous E2 on SSI and GH ReboundCompletedNCT02026973Phase 1
- Exemestane Plus Everolimus for Hormone-receptor Positive Metastatic Breast CancerStatus unknownNCT02025712Phase 2
- Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast CancerCompletedNCT01989780Phase 2
- Feasibility Study of Presurgical Hormone Therapy (Anastrozole) in Breast Cancer PatientsCompletedNCT01972984Phase 2
- Exemestane in Advanced and Recurrent Endometrial CarcinomaCompletedNCT01965080Phase 2
- Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing SurgeryActive, not recruitingNCT01953588Phase 3
- Trastuzumab Combined With Chemotherapy or Endocrine Therapy to Treat Metastatic Luminal B2 Breast CancerCompletedNCT01950182Phase 3
- Capecitabine Metronomic Chemotherapy Plus Aromatase Inhibitor for Postmenopausal Hormone Receptor Positive Breast CancerStatus unknownNCT01924078Phase 2
- Evaluation of Predictive Factors Regarding the Effectivity of Aromatase Inhibitor Therapy (PreFace)Status unknownNCT01908556Phase 4
- Impact of Estradiol AddbackCompletedNCT01862835Phase 1
- Constitutional Delay of Growth and Puberty: Towards Evidence-based TreatmentCompletedNCT01797718Phase 2/3
- BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast CancerCompletedNCT01791478Phase 1
- The Effects of Two Endometrium Preparation Protocols in Frozen-thawed Embryo Transfer in Women With Irregular CyclesStatus unknownNCT01780610Not applicable
- Anastrazole Plus GnRH-agonist in the Treatment of Endometriosis RecurrenceCompletedNCT01769781Phase 4
- Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase InhibitorsStatus unknownNCT01758146Phase 3
- Study to Compare Between Combimed Metformin-letrozole and Ovarian Drilling in Pcos With Bilateral Ovarian Drilling in Clomiphene-resistant Infertile Women With Polycystic Ovarian SyndromeCompletedNCT01693289Phase 1
- Letrozole or Combined Clomiphene Citrate Metformin as a First Line Treatment in Women With Polycystic Ovarian SyndromeCompletedNCT01679574Not applicable
- Exemestane, Pemetrexed Disodium, and Carboplatin in Treating Post-Menopausal Women With Stage IV Non-Small Cell Lung CancerCompletedNCT01664754Phase 1
- Research of Zoledronic Acid and Aromatase Inhibitors as Adjuvant Therapy to Breast CancerStatus unknownNCT01654367Phase 2/3
- Dimethyldiguanide Combined With Aromatase Inhibitor (AI) in Metastatic Breast CancerCompletedNCT01654185Phase 2
- Efficacy and Safety of TAC and Exemestane as Neoadjuvant Chemotherapy in the Postmenopausal Women With Breast CancerStatus unknownNCT01648608Phase 2/3
- Tamoxifen +/- GnRH Analogue vs Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer PatientsCompletedNCT01638247Phase 3
- Randomized Study of Letrozole and Trilostane for Medical AbortionTerminatedNCT01615211Phase 2
- Circulating miRNAs as Biomarkers of Hormone Sensitivity in Breast CancerCompletedNCT01612871Phase 4
- Treatment for Joint Pains Due to Aromatase Inhibitor Therapy in Breast CancerWithdrawnNCT01612728Phase 2
- The Effects of Letrozole And Clomiphene Citrate For Induction of Ovulation In Polycystic Ovarian Syndrome(PCOS)CompletedNCT01577017Phase 3
- Feasibility Study for the Determination of Oxysterols in Patients With Breast Cancer Receiving Hormonal Therapy With Tamoxifen or NotCompletedNCT01553903Phase 4
- Aromatase Inhibitor in Bone Maturation, Children With Silver Russell or Prader-Willi SyndromeStatus unknownNCT01520467Not applicable
- Study on Combined Use of Letrozole, Mifepristone and Misoprostol in Termination of PregnancyStatus unknownNCT01475318Not applicable
- Letrozole Versus Chinese Herbal Medicine on Polycystic Ovary Syndrome (PCOS)Status unknownNCT01431352Not applicable
- Study of Arimidex and Radiotherapy SequencingStatus unknownNCT01402193Phase 3
- Bioavailability Study of Letrozole Tablets 2.5 mg of Dr.Reddy's Under Fasting ConditionsCompletedNCT01375452Phase 1
- Bioavailability Study of Letrozole Tablets 2.5 mg of Dr.Reddy's Under Fed ConditionsCompletedNCT01372982Phase 1
- Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fasted ConditionsCompletedNCT01367652Phase 1
- Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fed ConditionsCompletedNCT01367626Phase 1
- Adjuvant AI Combined With ZoladexStatus unknownNCT01352091Phase 3
- Efficacy of Letrozole and CC Alone in an IUI Program in Cases With Surgically Treated Minimal to Mild EndometriosisCompletedNCT01334762Not applicable
- Pilot Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted ConditionsCompletedNCT01331447Not applicable
- Bioequivalency Study of Exemestane 25 mg Tablet Under Fed ConditionsCompletedNCT01331434Not applicable
- Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted ConditionsCompletedNCT01331421Not applicable
- Dosage Optimization for Letrozole TreatmentCompletedNCT01315912Phase 4
- 1st Line Treatment of Bevacizumab-Taxane vs Bevacizumab-Exemestane in Metastatic Breast CancerTerminatedNCT01303679Phase 3
- Influence of Aromatase Inhibitors and GnRH Analogs to Treat Uterine Leiomyoma by Vaginal HysterectomyTerminatedNCT01280045Not applicable
- Neoadjuvant Combined Endocrine and HER2 Target Therapy in Postmenopausal Women With ER and Her2 Positive Breast CancerCompletedNCT01275859Phase 2
- Fulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal WomenStatus unknownNCT01266213Phase 2
- Randomized Phase II Trial of Anastrozole Plus Metronomic Tegafur-uracil as Neo-adjuvant Therapy in Postmenopausal Breast CancerTerminatedNCT01262274Phase 2
- Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome ResistanceCompletedNCT01197170Phase 1
- Bioavailability Study of Anastrozole Tablets 1 mg of Dr.Reddy's Under Fed ConditionsCompletedNCT01155960Phase 1
- Bioavailability Study of Anastrozole Tablets 1 mg of Dr.Reddy's Under Fasting ConditionsCompletedNCT01155947Phase 1
- Bioequivalency Study of Anastrozole 1 mg Under Fasted ConditionsCompletedNCT01155102Not applicable
- Bioequivalency Study of Anastrozole 1 mg Under Fed ConditionsCompletedNCT01155089Not applicable
- Bioequivalence Study of Anastrozole 1 mg TabletCompletedNCT01105299Not applicable
- Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast CancerCompletedNCT01077453Phase 1
- Extended Adjuvant Treatment With Letrozole in Breast Cancer Who Complete 5 Years of ToremifeneStatus unknownNCT01072318Phase 4
- Letrozole in Treating Breast Cancer in Postmenopausal Women With Stage I, II, or III Breast Cancer Previously Treated With Tamoxifen (GIM4)Active, not recruitingNCT01064635Phase 3
- Aztreonam for Inhalation (AI) in Patients With Cystic Fibrosis & P. Aeruginosa InfectionCompletedNCT01055847Phase 2
- Aromatase Inhibitor Effects on Ovarian Function During the Follicular and Early Luteal Phase in WomenCompletedNCT01046578Phase 4
- Anastrozole Reduced Proliferation and Progesterone Receptor Indexes in Short Term Hormone TherapyCompletedNCT01016665Not applicable
- ELBA: Exemestane and Lapatinib in Advanced Breast CancerWithdrawnNCT01005641Phase 2
- Metabolic Effects of Steroids in Obese MenStatus unknownNCT00983554Not applicable
- Chemotherapy or Letrozole Before Surgery in Treating Postmenopausal Women With Breast Cancer That Can Be Removed By SurgeryCompletedNCT00963729Phase 3
- Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02CompletedNCT00963417Not applicable
- Letrozole or Laparoscopic Ovarian Diathermy for Women With CC Resistant Polycystic Ovary Syndrome.CompletedNCT00956267Not applicable
- Letrozole or Tamoxifen Citrate in Treating Older Postmenopausal Women Undergoing Surgery for Breast CancerCompletedNCT00949598Phase 3
- Aromatase Inhibitors for Treatment of Uterine LeiomyomasWithdrawnNCT00945360Phase 1
- Study of Faslodex With or Without Concomitant Arimidex Versus Exemestane Following Progression on Non-steroidal Aromatase Inhibitors (NSAI)CompletedNCT00944918Phase 3
- Exemestane (Aromasine) + Tamoxifen - Breast Neo-AdjuvantCompletedNCT00919399Phase 2
- Letrozole or Combined Metformin Clomiphene Citrate (CC) for Women With CC Resistant Polycystic Ovary SyndromeCompletedNCT00911313Not applicable
- Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast CancerTerminatedNCT00908531Phase 3
- Study of Exemestane After Anastrozole or Letrozole Treatment of Postmenopausal Women With Hormone Responsive Breast CancerStatus unknownNCT00902954Phase 3
- Letrozole Combined With Gonadotropins (Gn) for Ovarian Stimulation Undergoing in Vitro Fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI) in Patients With Polycystic Ovary Syndrome (PCOS)Status unknownNCT00894608Not applicable
- Letrozole, Anastrozole, Exemestane, or Tamoxifen Citrate in Treating Postmenopausal Women With Breast CancerCompletedNCT00893061Phase 3
- STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing)Status unknownNCT00887380Phase 3
- ATAC - Arimidex, Tamoxifen Alone or in CombinationCompletedNCT00849030Phase 3
- The Effect of Oxytocin (OT) and Oxytocin Plus Human Chorionic Gonadotropin (hCG), in Cycles Induced by Letrozole or Clomiphene CitrateCompletedNCT00844350Phase 2
- Antagonist/Letrozole in Poor RespondersCompletedNCT00823004Phase 1/2
- ATAC - Endometrial Sub-ProtocolCompletedNCT00814125Phase 3
- Adjuvant Post-Tamoxifen Exemestane TrialTerminatedNCT00810706Phase 3
- Does Letrozole Improve the Outcomes and/or Reduce the Cost of IVF-ET Cycles?WithdrawnNCT00804960Phase 4
- ATAC - Bone Density Sub-ProtocolCompletedNCT00784940Phase 3
- ATAC - Pharmacokinetics (PK) Sub-ProtocolCompletedNCT00784862Phase 3
- ATAC - Quality of Life Sub-ProtocolCompletedNCT00784680Phase 3
- A Study of Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast CancerCompletedNCT00773695Phase 2
- Pre-operative Hormonal Treatment for Hormone Receptor Positive Breast CancerSuspendedNCT00738777Phase 2